Open AccessDurable complete response in a patient with metastatic left‐sided colon cancer treated with 5‐fluorouracil, folinic acid, and irinotecan (FOLFIRI) and panitumumab: A case report
Author(s) -
Kim Esther,
Bay Graham H.,
Kim Christina A.
Publication year - 2019
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2210
Subject(s) - folinic acid , medicine , irinotecan , folfiri , fluorouracil , panitumumab , colorectal cancer , oncology , chemotherapy , cancer , cetuximab
There are rare patients with metastatic colon cancer who experience dramatic and durable responses. Primary tumor location is a prognostic and potentially predictive factor and should be taken into consideration when deciding on the optimal first‐line therapy to be used in combination with chemotherapy.